Women's Tabloid

Kindred Health Secures $5.5M in Funding to Improve Women’s Health

Follow Us:

Women's Tabloid News Desk
Women's Tabloid News Desk

Kindred Health, a femtech firm from Philippines, has bagged $2.5 million in the first tranche in its pre-Series A funding round. After achieving its key milestones, this firm also bagged an additional $3 million in the second tranche. This brings their funding total to a whooping $5.5 million.

Launched in 2021, being the first femtech firm to offer web-based telehealth service, Kindred became famous for providing accessible, affordable, and high-quality healthcare services for women. By 2023, Kindred raised $1 million in seed funding, opened its first clinic, and launched the Kindred mobile app.

The recent funding round was led by Integra Partners, with participation from Kaya Founders, KSR Ventures, Ava Zobel Pessina, Pawikan Capital Group, Tenco Capital, and individuals such as Dr. Frans Beltran and Micaela Beltran.

As of 2024, Kindred has expanded its customer base to more than 20,000 women, with over 40% of these clients returning for multiple visits, demonstrating strong alignment with market needs. To meet increasing demand, Kindred is opening a new clinic in Quezon City in July.

The latest round of funding was led by Integra Partners, supported by Kaya Founders, KSR Ventures, Ava Zobel Pessina, Pawikan Capital Group, Tenco Capital, and notable individuals including Dr. Frans Beltran and Micaela Beltran.

“We are deeply grateful to our investors for their trust and belief in our mission. This will enable us to scale our services, improve our technology, and increase our capacity to better serve our clients, paving the way for future generations of women in the Philippines,” said Jessica de Mesa-Lim, Co-Founder and CEO of Kindred.

“At Integra, we believe that women’s health is a huge market opportunity in Southeast Asia and globally, especially as the healthcare industry starts to gain a deeper understanding of how women manifest different symptoms and respond to treatments differently across a range of diseases and conditions,” said Jennifer Ho, partner at Integra Partners. “It’s been a privilege to work with Jess to map out the future of Kindred and how it can serve this burgeoning market.”

Share: